Quick Overview
- Aging is a network phenotype, not a single clock: damage, failed repair, altered signaling, and inflammation reinforce one another.
- Separate somatic aging from reproductive aging: ovarian reserve may decline while other tissues remain functional.
Core Facts & Concepts
- 🎯 Interacting hallmarks
- Genomic and epigenomic damage: mutations, DNA breaks, methylation drift, and declining repair.
- Telomere attrition: about 50-200 base pairs per somatic division; critically short ends activate p53/p21 and p16/Rb arrest.
- Mitochondrial dysfunction: mtDNA damage, reactive oxygen imbalance, and reduced ATP.
- Proteostasis loss: impaired chaperones, autophagy, and proteasomes permit misfolded aggregates.
- Cellular senescence: a viable, metabolically active, permanently growth-arrested cell secreting SASP such as IL-6, IL-8, and matrix metalloproteinases. Unlike apoptosis, it remains alive; apoptosis is caspase-mediated cell dismantling.
- Stem-cell exhaustion, altered nutrient sensing, and chronic inflammation reduce regeneration.
- Ovarian aging: finite primordial follicles undergo atresia. Lower AMH, inhibin B, and estradiol remove negative feedback, so FSH rises. Oocyte aneuploidy and fertility decline precede menopause, defined as 12 months of amenorrhea (average age about 51 years); this is not a universal somatic clock.
Problem-Solving Approach
- Case method
- Ask whether the cell is alive, metabolically active, and permanently unable to divide. If yes, SASP supports senescence.
- Caspases, DNA fragmentation, and apoptotic bodies indicate apoptosis; reversible arrest after growth signals indicates quiescence.
- Predict outcomes: senescent accumulation impairs repair and promotes paracrine inflammation or fibrosis; early arrest restrains tumors, but SASP can support a tumor microenvironment. Follicle depletion predicts infertility and irregular ovulation.
- Assess ovarian reserve with AMH or antral follicle count; interpret FSH and estradiol cautiously because they fluctuate.
- 🚩 Red flags: investigate amenorrhea before assuming aging; bleeding after menopause or amenorrhea before 45 years is not routine.
Analysis Framework & Visual Aid
- Discriminate by cell fate
| Feature | Senescence | Apoptosis | Quiescence |
|---|---|---|---|
| Viability | Alive, active | Dying or dead | Alive, low activity |
| Growth | Stable arrest | No proliferation | Reversible arrest |
| Markers | SASP, p16/p21, SA-beta-gal | Caspases, fragmentation | Growth-factor withdrawal |
| Consequence | Repair deficit, inflammation | Cell removal, little inflammation | Preserved re-entry |
- Decision rule: alive, permanent arrest, and SASP indicate senescence; cell death plus caspases indicates apoptosis.
- Visual workflow:
Loading diagram…
Key Points Summary
- Aging reflects interacting hallmarks, not one biomarker.
- 50-200 base pairs per division can trigger telomere checkpoints.
- Senescence is alive, active, arrested, and SASP-secreting; apoptosis removes cells.
- Stem-cell exhaustion and SASP impair repair; early senescence may suppress cancer but later promote a tumor niche.
- Follicle atresia lowers AMH, inhibin B, and estradiol while FSH rises; menopause requires 12 months amenorrhea, typically near 51 years.
- Fertility and oocyte quality decline before menopause; reproductive aging is not universal somatic aging.
📌 Remember: Alive, Arrested, Alarmed - senescent cells survive, stop dividing, and secrete SASP.
⚠️ Warning: Postmenopausal bleeding is pathologic until evaluated.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more